PET-PANC:multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer

Published on Feb 6, 2018in Health Technology Assessment3.37
· DOI :10.3310/HTA22070
Paula Ghaneh62
Estimated H-index: 62
(University of Liverpool),
Robert Hanson1
Estimated H-index: 1
(University of Liverpool)
+ 37 AuthorsJohn P. Neoptolemos125
Estimated H-index: 125
(University of Liverpool)
BACKGROUND: Pancreatic cancer diagnosis and staging can be difficult in 10-20% of patients. Positron emission tomography (PET)/computed tomography (CT) adds precise anatomical localisation to functional data. The use of PET/CT may add further value to the diagnosis and staging of pancreatic cancer. OBJECTIVE: To determine the incremental diagnostic accuracy and impact of PET/CT in addition to standard diagnostic work-up in patients with suspected pancreatic cancer. DESIGN: A multicentre prospective diagnostic accuracy and clinical value study of PET/CT in suspected pancreatic malignancy. PARTICIPANTS: Patients with suspected pancreatic malignancy. INTERVENTIONS: All patients to undergo PET/CT following standard diagnostic work-up. MAIN OUTCOME MEASURES: The primary outcome was the incremental diagnostic value of PET/CT in addition to standard diagnostic work-up with multidetector computed tomography (MDCT). Secondary outcomes were (1) changes in patients' diagnosis, staging and management as a result of PET/CT; (2) changes in the costs and effectiveness of patient management as a result of PET/CT; (3) the incremental diagnostic value of PET/CT in chronic pancreatitis; (4) the identification of groups of patients who would benefit most from PET/CT; and (5) the incremental diagnostic value of PET/CT in other pancreatic tumours. RESULTS: Between 2011 and 2013, 589 patients with suspected pancreatic cancer underwent MDCT and PET/CT, with 550 patients having complete data and in-range PET/CT. Sensitivity and specificity for the diagnosis of pancreatic cancer were 88.5% and 70.6%, respectively, for MDCT and 92.7% and 75.8%, respectively, for PET/CT. The maximum standardised uptake value (SUVmax.) for a pancreatic cancer diagnosis was 7.5. PET/CT demonstrated a significant improvement in relative sensitivity (p = 0.01) and specificity (p = 0.023) compared with MDCT. Incremental likelihood ratios demonstrated that PET/CT significantly improved diagnostic accuracy in all scenarios (p < 0.0002). PET/CT correctly changed the staging of pancreatic cancer in 56 patients (p = 0.001). PET/CT influenced management in 250 (45%) patients. PET/CT stopped resection in 58 (20%) patients who were due to have surgery. The benefit of PET/CT was limited in patients with chronic pancreatitis or other pancreatic tumours. PET/CT was associated with a gain in quality-adjusted life-years of 0.0157 (95% confidence interval -0.0101 to 0.0430). In the base-case model PET/CT was seen to dominate MDCT alone and is thus highly likely to be cost-effective for the UK NHS. PET/CT was seen to be most cost-effective for the subgroup of patients with suspected pancreatic cancer who were thought to be resectable. CONCLUSION: PET/CT provided a significant incremental diagnostic benefit in the diagnosis of pancreatic cancer and significantly influenced the staging and management of patients. PET/CT had limited utility in chronic pancreatitis and other pancreatic tumours. PET/CT is likely to be cost-effective at current reimbursement rates for PET/CT to the UK NHS. This was not a randomised controlled trial and therefore we do not have any information from patients who would have undergone MDCT only for comparison. In addition, there were issues in estimating costs for PET/CT. Future work should evaluate the role of PET/CT in intraductal papillary mucinous neoplasm and prognosis and response to therapy in patients with pancreatic cancer. STUDY REGISTRATION: Current Controlled Trials ISRCTN73852054 and UKCRN 8166. FUNDING: The National Institute for Health Research Health Technology Assessment programme.
Figures & Tables
📖 Papers frequently viewed together
66 Citations
8 Citations
3 Citations
#1B. JaisH-Index: 1
#2Vinciane ReboursH-Index: 38
Last. Philippe LévyH-Index: 57
view all 88 authors...
Objectives Serous cystic neoplasm (SCN) is a cystic neoplasm of the pancreas whose natural history is poorly known. The purpose of the study was to attempt to describe the natural history of SCN, including the specific mortality. Design Retrospective multinational study including SCN diagnosed between 1990 and 2014. Results 2622 patients were included. Seventy-four per cent were women, and median age at diagnosis was 58 years (16–99). Patients presented with non-specific abdominal pain (27%), pa...
146 CitationsSource
#1Pratyusha Nunna (Johns Hopkins University)H-Index: 2
#2Sara Sheikhbahaei (Johns Hopkins University)H-Index: 33
Last. Rathan M. SubramaniamH-Index: 41
view all 5 authors...
Abstract The role of positron emission tomography (PET) and PET/computed tomography (CT) in the management of pancreatic cancer patients has not been clearly established. Although value of PET/CT in the staging of pancreatic cancer is still being debated, several studies pointed to its superior role in determining therapy response, recurrence detection, and survival prediction in comparison to conventional imaging including contrast-enhanced CT. This article reviews the current literature on use...
5 CitationsSource
#1Richard KimH-Index: 3
#2Gopi PrithvirajH-Index: 1
Last. Amit Mahipal (USF: University of South Florida)H-Index: 25
view all 10 authors...
Background In pancreatic cancer, early detection and complete surgical resection with negative margins offers the only cure for the disease. Work up to evaluate resectability includes triple phase helical scan CT of the pancreas and endoscopic ultrasound (EUS). A paucity of data exists in using PET/CT scan as staging work up in early resectable pancreatic cancer. The objective of our study was to determine if PET/CT prevents futile laparotomy by detecting occult metastatic disease in patients wi...
18 CitationsSource
#1Côme Lepage (French Institute of Health and Medical Research)H-Index: 37
#2Riccardo CapocacciaH-Index: 62
Last. Jean Faivre (French Institute of Health and Medical Research)H-Index: 77
view all 9 authors...
Abstract Background The EUROCARE study collects and analyses survival data from population-based cancer registries (CRs) in Europe in order to provide data on between-country differences in survival and time trends in survival. Methods This study analyses data on liver cancer, gallbladder and extrahepatic biliary tract cancers (“biliary tract cancers”), and pancreatic cancer diagnosed in 2000–2007 from 88 CRs in 29 countries. Relative survival (RS) was estimated overall, by region, sex, age and ...
78 CitationsSource
#1Tomasz P. Radon (QMUL: Queen Mary University of London)H-Index: 9
#2Nathalie J. Massat (QMUL: Queen Mary University of London)H-Index: 13
Last. Tatjana Crnogorac-Jurcevic (QMUL: Queen Mary University of London)H-Index: 34
view all 18 authors...
Purpose: Noninvasive biomarkers for early detection of pancreatic ductal adenocarcinoma (PDAC) are currently not available. Here, we aimed to identify a set of urine proteins able to distinguish patients with early-stage PDAC from healthy individuals. Experimental design: Proteomes of 18 urine samples from healthy controls, chronic pancreatitis, and patients with PDAC (six/group) were assayed using GeLC/MS/MS analysis. The selected biomarkers were subsequently validated with ELISA assays using m...
96 CitationsSource
#1Matthew Burge (Royal Brisbane and Women's Hospital)H-Index: 14
#2Nicholas O'Rourke (Royal Brisbane and Women's Hospital)H-Index: 24
Last. David Macfarlane (Royal Brisbane and Women's Hospital)H-Index: 17
view all 12 authors...
Abstract Background The role of fluorodeoxyglucose (FDG) positron emission tomography (PET/CT) scanning in operable pancreas cancer is unclear. We, therefore, wanted to investigate the impact of PET/CT on management, by incorporating it into routine work‐up. Methods This was a single‐institution prospective study. Patients with suspected and potentially operable pancreas, distal bile duct or ampullary carcinomas underwent PET/CT in addition to routine work‐up. The frequency that PET/CT changed t...
18 CitationsSource
#1Natsuko KawadaH-Index: 17
#2Hiroyuki UeharaH-Index: 26
Last. Yasuhiko TomitaH-Index: 56
view all 7 authors...
Abstract The usefulness of dual-phase F-fluorodeoxyglucose (F-FDG) positron emission tomography/computed tomography (PET/CT) for pancreatic tumors was investigated including numerous small tumors. Consecutive 116 patients with solid pancreatic tumors were subjected. Maximum standard uptake values (SUVmax) at 1 and 2 hours after FDG injection were defined as early and delayed SUVmax, respectively. Receiver operating characteristic curve was used to determine the optimal cutoff value of early SUVm...
20 CitationsSource
#1Jian Zhang ('SMMU': Second Military Medical University)H-Index: 5
#2Changjing Zuo ('SMMU': Second Military Medical University)H-Index: 9
Last. Xiao-Yuan Feng ('SMMU': Second Military Medical University)H-Index: 2
view all 9 authors...
AIM: To explore the diagnostic value of the cross-modality fusion images provided by positron emission tomography/computed tomography (PET/CT) and contrast-enhanced CT (CECT) for pancreatic cancer (PC). METHODS: Data from 70 patients with pancreatic lesions who underwent CECT and PET/CT examinations at our hospital from August 2010 to October 2012 were analyzed. PET/CECT for the cross-modality image fusion was obtained using TureD software. The diagnostic efficiencies of PET/CT, CECT and PET/CEC...
18 CitationsSource
#1Tomohiro Yoneyama (YCU: Yokohama City University)H-Index: 7
#2Ukihide Tateishi (YCU: Yokohama City University)H-Index: 51
Last. Tomio Inoue (YCU: Yokohama City University)H-Index: 38
view all 4 authors...
Abstract Purpose Our aim was to clarify the diagnostic impact of contrast-enhanced (CE) 18F-fluorodeoxyglucose (FDG)–positron emission tomography (PET)/computed tomography (CT) for staging of pancreatic cancer compared to non-CE PET/CT. Method and materials Between April 2006 and November 2009, a total of 95 patients (age range, 36–83 years [mean age, 67]) with primary pancreatic cancer underwent 18F-FDG PET/CT examinations. Diagnostic accuracy was compared between non-CE PET/CT and CE PET/CT. I...
15 CitationsSource
#1G.A. Gooiker (LEI: Leiden University)H-Index: 17
#2Valery E.P.P. Lemmens (EUR: Erasmus University Rotterdam)H-Index: 65
Last. Michel W.J.M. Wouters (LEI: Leiden University)H-Index: 53
view all 9 authors...
Centralization of pancreatic surgery has been shown to reduce postoperative mortality. It is unknown whether resection rates and survival have also improved. The aim of this study was to analyse the impact of nationwide centralization of pancreatic surgery on resection rates and long-term survival. All patients diagnosed in the Netherlands between 2000 and 2009 with cancer of the pancreatic head were identified in the Netherlands Cancer Registry. Changes in referral pattern, resection rates and ...
139 CitationsSource
Cited By76
#1Marta Sandini (Heidelberg University)H-Index: 3
#1Marta SandiniH-Index: 15
Last. John P. NeoptolemosH-Index: 125
view all 5 authors...
#1Benjamin LovedayH-Index: 2
#2John A. WindsorH-Index: 2
#1Nana Hyldig (University of Southern Denmark)H-Index: 5
#2Jan Stener Joergensen (University of Southern Denmark)H-Index: 11
Last. Christina Anne Vinter (Odense University)
view all 6 authors...
Further debate about the effect of incisional negative pressure wound therapy (iNPWT) versus standard wound dressing on surgical-site infection (SSI) in obese women after caesarean section (CS) has resurfaced. This is because of a study published in JAMA1 that was stopped early on the grounds of "futility". This was counterintuitive to us having published a systematic review,2 a randomised controlled trial (RCT)3 and a health economic evaluation on the same subject,4 the latter two of which were...
#1Sarah Blacker (Royal Surrey County Hospital)
#2Rajiv P. Lahiri (Royal Surrey County Hospital)H-Index: 1
Last. Adam E Frampton (Royal Surrey County Hospital)H-Index: 33
view all 11 authors...
Recent studies have indicated that preoperative biliary drainage (PBD) should not be routinely performed in all patients suffering from obstructive jaundice before pancreatic surgery. The severity of jaundice that mandates PBD has yet to be defined. The evaluated paper examines the impact of PBD on intra-operative, and post-operative outcomes in patients initially presenting with severe obstructive jaundice (bilirubin ≥250 μmol/L). In this key paper evaluation, the impact of PBD versus a direct ...
#1Marc A Attiyeh (City of Hope National Medical Center)
#2Arya Amini (City of Hope National Medical Center)H-Index: 22
Last. Laleh G. Melstrom (City of Hope National Medical Center)H-Index: 29
view all 4 authors...
The annual incidence of pancreatic cancer is nearly 50,000 patients. The 5-year overall survival is only 9%, and there remains a great need for better therapy. A subset of these patients presents with locally advanced disease. Multidisciplinary therapy has evolved to include some combination of systemic chemotherapy, locoregional radiation, and surgery in select patients with excellent biology. This review will address the thoughtful evidence-based and individualized approach to these patients.
#1Venkata Subramanian Krishnaraju (PGIMER: Post Graduate Institute of Medical Education and Research)H-Index: 1
#2Rajender Kumar (PGIMER: Post Graduate Institute of Medical Education and Research)H-Index: 6
Last. Surinder Singh Rana (PGIMER: Post Graduate Institute of Medical Education and Research)H-Index: 27
view all 10 authors...
Differentiation of malignant and benign pancreatic lesions on anatomical imaging is difficult in some cases with overlapping features. Prostate-specific membrane antigen (PSMA) is overexpressed during angioneogenesis in many tumors. We aimed to evaluate the PSMA expression in pancreatic lesions to differentiate these lesions and explore the performance of Ga-68 PSMA-PET/CT vis-a-vis F-18 FDG-PET/CT. Patients with pancreatic lesions on conventional imaging were prospectively recruited. All the pa...
#1Berit Bargum Booth (AU: Aarhus University)H-Index: 1
#1Berit Bargum Booth (University of Southern Denmark)
Last. Pinar BorH-Index: 8
view all 9 authors...
OBJECTIVE The aim of the study was to evaluate the sensitivity of dynamic spectral imaging (DSI) colposcopy compared with regular colposcopy for women referred with high-grade cervical cytology. METHODS In a prospective, nonrandomized, multicenter study, we included women referred for colposcopy at hospital gynecology clinics with high-grade cytology. Women were examined using either a regular or DSI colposcope. In both groups, colposcopists located 1 area viewed as most suspicious. In the DSI g...
#1Christian Brandt (Bethel University)H-Index: 30
#2Birgitt Müffelmann (Bethel University)
Last. Christian G. Bien (Bethel University)H-Index: 63
view all 8 authors...
Abstract Introduction The aim of the study was to determine the impact of a comprehensive inpatient treatment program for persons with epilepsy and intellectual disability (ID) on the concerns of relatives and caregivers, quality of life (QoL), and global health and clinical aspects, assessed by a questionnaire for relatives and caregivers. Methods We performed an open, controlled pre/post study in inpatients with epilepsy and ID or acquired brain damage treated for at least 14 days in a tertiar...
#1Sarah Powell-BrettH-Index: 1
#1Powell-Brett S (University Hospitals Birmingham NHS Foundation Trust)
Last. Fujii T
view all 3 authors...
Improving outcomes among patients with resectable pancreatic cancer is one of the greatest challenges of modern medicine. Major improvements in survival will result from the development of novel therapies. However, optimising existing pathways, so that patients realise benefits of already proven treatments, presents a clear opportunity to improve outcomes in the short term. This narrative review will focus on treatments and interventions where there is a clear evidence base to improve outcomes i...